Shares of BioNTech SE have moved -4.2% today, and are now trading at a price of $147.2. In contrast, the S&P 500 index saw a 0.6% change. Today's trading volume is 362,772 compared to the stock's average volume of 972,777.
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. Based in Mainz, Germany the company has 3,082 full time employees and a market cap of $35,699,421,184.
The company is now trading -34.26% away from its average analyst target price of $223.91 per share. The 14 analysts following the stock have set target prices ranging from $149.47 to $314.09, and on average give BioNTech SE a rating of buy.
A string of strong margins growth bodes well for the company's future:
|Date Reported||Revenue ($ MM)||Cost of Revenue ($ MM)||Gross Margins (%)||YoY Growth (%)|